Rating: 0 out of 5 stars
0 ratings
Unavailable
Unavailable
Unavailable
Ebook1,369 pages40 hours
Therapeutic Antibody Engineering: Current and Future Advances Driving the Strongest Growth Area in the Pharmaceutical Industry
By William R Strohl and Lila M Strohl
Rating: 5 out of 5 stars
5/5
()
Currently unavailable
Currently unavailable
About this ebook
The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas. Therapeutic antibody engineering examines all aspects of engineering monoclonal antibodies and analyses the effect that various genetic engineering approaches will have on future candidates. Chapters in the first part of the book provide an introduction to monoclonal antibodies, their discovery and development and the fundamental technologies used in their production. Following chapters cover a number of specific issues relating to different aspects of antibody engineering, including variable chain engineering, targets and mechanisms of action, classes of antibody and the use of antibody fragments, among many other topics. The last part of the book examines development issues, the interaction of human IgGs with non-human systems, and cell line development, before a conclusion looking at future issues affecting the field of therapeutic antibody engineering.
- Goes beyond the standard engineering issues covered by most books and delves into structure-function relationships
- Integration of knowledge across all areas of antibody engineering, development, and marketing
- Discusses how current and future genetic engineering of cell lines will pave the way for much higher productivity
Unavailable
Author
William R Strohl
Dr William R. Strohl is Vice President of Biologics Research at Janssen R&D Biotechnology Center of Excellence, and was previously a leader in Merck’s efforts to discover therapeutic monoclonal antibodies, as well as in-licensing of therapeutic targets and technologies associated with monoclonal antibodies. He has over 100 publications and several patents to his credit, and has edited two books.
Related authors
Related to Therapeutic Antibody Engineering
Related ebooks
Biological Drug Products: Development and Strategies Introduction to Biological and Small Molecule Drug Research and Development: Theory and Case Studies Rating: 5 out of 5 stars5/5A Biotech Manager's Handbook: A Practical Guide Rating: 3 out of 5 stars3/5Monoclonal Antibody Technology: The Production and Characterization of Rodent and Human Hybridomas Rating: 4 out of 5 stars4/5Translational Biotechnology: A Journey from Laboratory to Clinics Rating: 0 out of 5 stars0 ratingsPharmaceutical Medicine and Translational Clinical Research Rating: 0 out of 5 stars0 ratingsPharmaceutical Biotechnology: Drug Discovery and Clinical Applications Rating: 0 out of 5 stars0 ratingsProduction of Plasma Proteins for Therapeutic Use Rating: 3 out of 5 stars3/5Chemoinformatics and Bioinformatics in the Pharmaceutical Sciences Rating: 0 out of 5 stars0 ratingsFrontiers in Medicinal Chemistry: Volume 8 Rating: 0 out of 5 stars0 ratingsBiosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development Rating: 0 out of 5 stars0 ratingsBioprocess Engineering: Kinetics, Sustainability, and Reactor Design Rating: 5 out of 5 stars5/5Protein Purification: Principles, High Resolution Methods, and Applications Rating: 0 out of 5 stars0 ratingsNonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations Rating: 0 out of 5 stars0 ratingsNonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics Rating: 0 out of 5 stars0 ratingsMonoclonal Antibodies: Principles and Practice Rating: 0 out of 5 stars0 ratingsThe Path from Biomarker Discovery to Regulatory Qualification Rating: 0 out of 5 stars0 ratingsMonoclonal Antibodies: Physicochemical Analysis Rating: 0 out of 5 stars0 ratingsFundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines Rating: 5 out of 5 stars5/5Process Scale Purification of Antibodies Rating: 0 out of 5 stars0 ratingsPeptide and Protein Delivery Rating: 2 out of 5 stars2/5Challenges in Delivery of Therapeutic Genomics and Proteomics Rating: 0 out of 5 stars0 ratingsTranslating Gene Therapy to the Clinic: Techniques and Approaches Rating: 0 out of 5 stars0 ratingsGuidebook for Drug Regulatory Submissions Rating: 0 out of 5 stars0 ratingsGuide to Cell Therapy GxP: Quality Standards in the Development of Cell-Based Medicines in Non-pharmaceutical Environments Rating: 0 out of 5 stars0 ratingsPractice and Theory of Enzyme Immunoassays Rating: 0 out of 5 stars0 ratingsMicrofluidics for Pharmaceutical Applications: From Nano/Micro Systems Fabrication to Controlled Drug Delivery Rating: 0 out of 5 stars0 ratingsFormulation and Process Development Strategies for Manufacturing Biopharmaceuticals Rating: 0 out of 5 stars0 ratingsMass Spectrometry for the Clinical Laboratory Rating: 0 out of 5 stars0 ratings
Science & Mathematics For You
Feeling Good: The New Mood Therapy Rating: 4 out of 5 stars4/5The Wisdom of Psychopaths: What Saints, Spies, and Serial Killers Can Teach Us About Success Rating: 4 out of 5 stars4/5The Gulag Archipelago [Volume 1]: An Experiment in Literary Investigation Rating: 4 out of 5 stars4/5Outsmart Your Brain: Why Learning is Hard and How You Can Make It Easy Rating: 4 out of 5 stars4/5Other Minds: The Octopus, the Sea, and the Deep Origins of Consciousness Rating: 4 out of 5 stars4/5The Gulag Archipelago: The Authorized Abridgement Rating: 4 out of 5 stars4/5The Dorito Effect: The Surprising New Truth About Food and Flavor Rating: 4 out of 5 stars4/5The Big Book of Hacks: 264 Amazing DIY Tech Projects Rating: 4 out of 5 stars4/5Becoming Cliterate: Why Orgasm Equality Matters--And How to Get It Rating: 4 out of 5 stars4/5Activate Your Brain: How Understanding Your Brain Can Improve Your Work - and Your Life Rating: 4 out of 5 stars4/5A Letter to Liberals: Censorship and COVID: An Attack on Science and American Ideals Rating: 3 out of 5 stars3/5The Systems Thinker: Essential Thinking Skills For Solving Problems, Managing Chaos, Rating: 4 out of 5 stars4/5The Big Fat Surprise: Why Butter, Meat and Cheese Belong in a Healthy Diet Rating: 4 out of 5 stars4/5How Emotions Are Made: The Secret Life of the Brain Rating: 4 out of 5 stars4/5Why People Believe Weird Things: Pseudoscience, Superstition, and Other Confusions of Our Time Rating: 4 out of 5 stars4/5On Food and Cooking: The Science and Lore of the Kitchen Rating: 5 out of 5 stars5/5The Rise of the Fourth Reich: The Secret Societies That Threaten to Take Over America Rating: 4 out of 5 stars4/5The Invisible Rainbow: A History of Electricity and Life Rating: 4 out of 5 stars4/5Lies My Gov't Told Me: And the Better Future Coming Rating: 4 out of 5 stars4/5The Psychology of Totalitarianism Rating: 5 out of 5 stars5/5Free Will Rating: 4 out of 5 stars4/5The Science of Monsters: The Origins of the Creatures We Love to Fear Rating: 4 out of 5 stars4/5Suicidal: Why We Kill Ourselves Rating: 4 out of 5 stars4/5The Misinformation Age: How False Beliefs Spread Rating: 4 out of 5 stars4/5Ultralearning: Master Hard Skills, Outsmart the Competition, and Accelerate Your Career Rating: 4 out of 5 stars4/5The Gulag Archipelago [Volume 2]: An Experiment in Literary Investigation Rating: 4 out of 5 stars4/5Born for Love: Why Empathy Is Essential--and Endangered Rating: 4 out of 5 stars4/52084: Artificial Intelligence and the Future of Humanity Rating: 4 out of 5 stars4/5A Crack In Creation: Gene Editing and the Unthinkable Power to Control Evolution Rating: 4 out of 5 stars4/5
Related podcast episodes
Episode 11: "Olu the Drunk Snowman" - IDH inhibitors in R/R AML with Dr. Jill Lykon 0% found this document usefulBeyond Biotech podcast 23: World Antimicrobial Awareness Week, PsychoGenics 0% found this document useful129: AR Lab Network, GN7F panel, and more 0% found this document useful
Related articles
Personalised Medicine: More Than Just Personal AQ: Australian QuarterlyArticle
Personalised Medicine: More Than Just Personal
Mar 31, 2017
9 min readThe Modern, Secular Godparent The AtlanticArticle
The Modern, Secular Godparent
May 21, 2019
7 min readOpinion: Companies Must Responsibly Manufacture The Antimicrobials Society Needs STATArticle
Opinion: Companies Must Responsibly Manufacture The Antimicrobials Society Needs
Jan 30, 2020
Providing access to antibiotics and other antimicrobials while reducing resistance to these medicines presents a dual manufacturing challenge: ensuring a cost-effective supply while minimizing their emission into the environment.
4 min readMedical Promise At A Reasonable Price MoneyWeekArticle
Medical Promise At A Reasonable Price
Dec 15, 2023
2 min readOpinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine STATArticle
Opinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine
Oct 2, 2018
When it comes to #microbiome medicine, @US_FDA and @NIH need to create a solid, science-based regulatory framework to help realize the promise of living drugs.
4 min readRemember, Remember The 2020 November PC Pro MagazineArticle
Remember, Remember The 2020 November
Jan 7, 2021
World-changing innovations are like London buses: you wait for years and then three come along at once. The recent wait has been particularly irksome, as virology and epidemiology felt like the only relevant sciences in lockdown – apart from rocket s
3 min readOpinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials STATArticle
Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials
Feb 5, 2019
Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.
4 min readOpinion: U.S. Biologics And Biosimilars Need Distinguishable Names STATArticle
Opinion: U.S. Biologics And Biosimilars Need Distinguishable Names
Apr 23, 2019
Creating distinguishable nonproprietary names for biologics and their biosimilars will help ensure that patients get the right medications and will be useful for identifying adverse events more readily.
5 min readThe Debate India TodayArticle
The Debate
May 2, 2020
1 min readLET’S RESIST THE temptation… Your HorseArticle
LET’S RESIST THE temptation…
Apr 25, 2024
7 min readBiomaterial Package Delivers Chemo and Fights Resistance FuturityArticle
Biomaterial Package Delivers Chemo and Fights Resistance
Aug 15, 2017
2 min readDrug May Dial Down Arthritis Inflammation FuturityArticle
Drug May Dial Down Arthritis Inflammation
Mar 30, 2018
2 min readMerck And Sanofi Buy Smaller Cancer Drug Firms At Big Premiums, Fueling Investor Excitement STATArticle
Merck And Sanofi Buy Smaller Cancer Drug Firms At Big Premiums, Fueling Investor Excitement
Dec 9, 2019
Merger Monday: Merck announces it will purchase ArQule, a developer of pills aimed at treating multiple cancers, and Sanofi says it will buy Synthorx, a San Diego firm working on…
3 min readThe ‘Other Vaccine’: Why The Imperial Jab Offers A Different Kind Of Hope In The Fight Against Covid-19 The IndependentArticle
The ‘Other Vaccine’: Why The Imperial Jab Offers A Different Kind Of Hope In The Fight Against Covid-19
Nov 10, 2020
5 min readFive Coronavirus Treatments In Development NPRArticle
Five Coronavirus Treatments In Development
Jun 11, 2020
3 min readWhy Synthetic Protein Research Needs More Funding NautilusArticle
Why Synthetic Protein Research Needs More Funding
Jun 4, 2017
4 min readCOPYCATS: Where Fashion And Pharmaceuticals Meet The European Business ReviewArticle
COPYCATS: Where Fashion And Pharmaceuticals Meet
Jun 3, 2019
15 min readBedside Drug Production Will Truly Enable Personalized Medicine STATArticle
Bedside Drug Production Will Truly Enable Personalized Medicine
Jun 19, 2017
4 min readOpinion: CRISPR-Cas9 Commercialization May Be Slowed By Delivery And Manufacturing Challenges STATArticle
Opinion: CRISPR-Cas9 Commercialization May Be Slowed By Delivery And Manufacturing Challenges
Feb 1, 2019
4 min readOpinion: Combatting Misinformation On Biosimilars And Preparing The Market For Them Can Save The U.S. Billions STATArticle
Opinion: Combatting Misinformation On Biosimilars And Preparing The Market For Them Can Save The U.S. Billions
Jun 19, 2019
For more than a decade, biosimilars have flourished in Europe. That hasn't happened in the U.S. because of misinformation and poor market preparation.
5 min readOpinion: A Quantum Of Innovation And The Incentives To Match STATArticle
Opinion: A Quantum Of Innovation And The Incentives To Match
Mar 7, 2019
Modest tweaks to drugs, what some dismiss as "merely incremental," can represent real and compelling advances for patients and offer great value over time.
9 min readOpinion: Manufacturing: The Next Breakthrough In Gene Therapy STATArticle
Opinion: Manufacturing: The Next Breakthrough In Gene Therapy
Dec 18, 2019
As the race heats up to bring gene therapy to market, breakthroughs in manufacturing are often the key — or break down the barrier — to delivering these therapies to…
3 min readHow To Invest In Medical Innovation MoneyWeekArticle
How To Invest In Medical Innovation
May 26, 2023
4 min readOpinion: In Pricing Our Gene Therapy, Bluebird Weighed Value, Shared Risk, And A Lifetime Cap STATArticle
Opinion: In Pricing Our Gene Therapy, Bluebird Weighed Value, Shared Risk, And A Lifetime Cap
Nov 26, 2019
A gene therapy might deliver a lifetime of benefit, but it doesn’t deserve a lifetime of payment.
4 min readCommentary: If We Want Cures To Diseases Like COVID-19, We Should Stop Vilifying Drug Companies Chicago TribuneArticle
Commentary: If We Want Cures To Diseases Like COVID-19, We Should Stop Vilifying Drug Companies
Nov 4, 2021
3 min readOpinion: Combination Immunotherapy May Have Failed In The Incyte/Merck Trial, But It’s Here To Stay STATArticle
Opinion: Combination Immunotherapy May Have Failed In The Incyte/Merck Trial, But It’s Here To Stay
Apr 23, 2018
4 min readOpinion: I Hope The Departure Of ‘Tech-savvy’ Gottlieb Won’t Undo Progress At The FDA STATArticle
Opinion: I Hope The Departure Of ‘Tech-savvy’ Gottlieb Won’t Undo Progress At The FDA
Mar 7, 2019
4 min readOpinion: What’s Holding Pharma Back From The Next Antibiotic Breakthrough? STATArticle
Opinion: What’s Holding Pharma Back From The Next Antibiotic Breakthrough?
Dec 10, 2018
5 min readHow Robot Math and Smartphones Led Researchers to a Drug Discovery Breakthrough AppleMagazineArticle
How Robot Math and Smartphones Led Researchers to a Drug Discovery Breakthrough
Jan 19, 2018
3 min readDr. William Levine Cannabis & Tech TodayArticle
Dr. William Levine
Jan 3, 2020
5 min read
Reviews for Therapeutic Antibody Engineering
Rating: 5 out of 5 stars
5/5
1 rating0 reviews